MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)

|||

Balance Sheets Overview

Current Ratio
710.28%
Quick Ratio
683.89%
Cash Ratio
570.90%
Debt to Asset Ratio
11.76%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Deferred tax assets, net
    • Others
Liabilities Breakdown
    • Retained earnings
    • Additional paid-in capital
    • Accrued expenses and other liabi...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
755,859
709,171
689,892
652,800
Accounts receivable, net
130,834
126,477
106,409
65,863
Inventory
34,930
37,166
28,029
18,650
Prepaid expenses and other current assets
18,767
21,216
28,123
21,426
Total current assets
940,390
894,030
852,453
758,739
Operating lease right-of-use asset, net
1,858
1,935
2,010
2,084
Property and equipment, net
994
1,037
1,077
1,149
License and acquired intangibles, net
121,971
131,674
128,639
137,983
Deferred tax assets, net
55,111
52,767
48,256
50,704
Investment in equity securities
27,286
22,536
19,167
21,256
Total assets
1,147,610
1,103,979
1,051,602
971,915
Accounts payable
7,151
11,202
9,096
5,528
Accrued expenses and other liabilities
125,247
135,950
119,639
107,479
Total current liabilities
132,398
147,152
128,735
113,007
Operating lease liability, net of current portion
2,235
2,350
2,461
2,572
Other non-current liabilities
280
209
161
309
Total liabilities
134,913
149,711
131,357
115,888
Common stock, 0.001 par value, 200,000,000 shares authorized 122,181,308 shares and 122,513,621 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
122
123
123
122
Additional paid-in capital
489,218
479,957
473,333
461,868
Retained earnings
523,349
474,188
446,789
394,006
Accumulated other comprehensive income (loss) (note 4)
8
0
0
31
Total stockholders' equity
1,012,697
954,268
920,245
856,027
Total liabilities and stockholders' equity
1,147,610
1,103,979
1,051,602
971,915
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$755,859K Accounts receivable, net$130,834K Inventory$34,930K Prepaid expenses andother current assets$18,767K Total current assets$940,390K License and acquiredintangibles, net$121,971K Deferred tax assets, net$55,111K Investment in equitysecurities$27,286K Operating leaseright-of-use asset, net$1,858K Property and equipment,net$994K Total assets$1,147,610K Total liabilities andstockholders' equity$1,147,610K Total stockholders'equity$1,012,697K Total liabilities$134,913K Retained earnings$523,349K Additional paid-in capital$489,218K Common stock, 0.001 parvalue, 200,000,000...$122K Accumulated othercomprehensive income (loss)...$8K Total currentliabilities$132,398K Operating leaseliability, net of current...$2,235K Other non-currentliabilities$280K Accrued expenses andother liabilities$125,247K Accounts payable$7,151K